Postmarketing assessment of a switchable similar anastrozole product in Brazilian breast cancer patients

Postmarketing assessment of a switchable similar anastrozole product in Brazilian breast cancer patients

Several formulations of the aromatase inhibitor anastrozole are available in Brazil. We carried out a postmarketing surveillance of the anastrozole (test) formulation in current use at the Brazilian National Cancer Institute (INCA), by comparing anastrozole through plasma concentrations obtained wit...

Full description

Bibliographic Details
Main Authors: Manuela Vasquez Cardoso, Renata Obadia, Luna Silva, Priscila Pentagna, Rafael Linden, Vanessa Câmara Fernandes, Andreia Cristina de Melo, Guilherme Suarez-Kurtz
Format: Article
Language:English
Published: Sociedade Brasileira de Oncologia Clínica, Sociedade Brasileira de Cirurgia Clínica and Sociedade Brasileira de Radioterapia 2023-04-01
Series:Brazilian Journal of Oncology
Subjects:
aromatase inhibitors
anastrozole
breast neoplasms
Online Access:https://www.brazilianjournalofoncology.com.br/details/232/en-US/postmarketing-assessment-of-a-switchable-similar-anastrozole-product-in-brazilian-breast-cancer-patients

Internet

https://www.brazilianjournalofoncology.com.br/details/232/en-US/postmarketing-assessment-of-a-switchable-similar-anastrozole-product-in-brazilian-breast-cancer-patients

Similar Items